XENE (Xenon Pharmaceuticals) Pretax Margin %: % (As of Mar. 2026)

What is Xenon Pharmaceuticals Pretax Margin %?

Xenon Pharmaceuticals XENE +5.21% 25 Pretax Margin % is % as of Mar. 2026. GuruFocus rates XENE with a GF Score™ of 25/100. The stock has 5 warning signs investors should review. Among 946 Biotechnology companies, Xenon Pharmaceuticals ranks worse than 105708.14% on this metric.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Xenon Pharmaceuticals's Pre-Tax Income for the three months ended in Mar. 2026 was $-104.87 Mil. Xenon Pharmaceuticals's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Xenon Pharmaceuticals's pretax margin for the quarter that ended in Mar. 2026 was %.

The historical rank and industry rank for Xenon Pharmaceuticals's Pretax Margin % or its related term are showing as below:

XENE's Pretax Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -90.5
* Ranked among companies with meaningful Pretax Margin % only.

Xenon Pharmaceuticals (NAS:XENE) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Xenon Pharmaceuticals Pretax Margin % Related Terms

Xenon Pharmaceuticals Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Xenon Pharmaceuticals's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xenon Pharmaceuticals Pretax Margin % Chart

Xenon Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Pretax Margin %

Get a 7-Day Free Trial

-427.88

-1,327.70

0.00

-4,598.59

Xenon Pharmaceuticals Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Pretax Margin %	Get a 7-Day Free Trial															-861.60	0.00	0.00	0.00	0.00

XENE vs CRSP, CGON, DNTH: Pretax Margin % Comparison

For the Biotechnology subindustry, Xenon Pharmaceuticals's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Xenon Pharmaceuticals Pretax Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Xenon Pharmaceuticals's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Xenon Pharmaceuticals's Pretax Margin % falls into.

Save Embed

25GF Score

Xenon Pharmaceuticals Inc XENE

Pretax Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Xenon Pharmaceuticals Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Xenon Pharmaceuticals's Pretax Margin for the fiscal year that ended in Dec. 2025 is calculated as

Pretax Margin	=	Pre-Tax Income (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-344.894	/	7.5
	=	-4,598.59 %

Xenon Pharmaceuticals's Pretax Margin for the quarter that ended in Mar. 2026 is calculated as

Pretax Margin	=	Pre-Tax Income (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	-104.873	/	0
	=	%

Frequently Asked Questions Learn more about Pretax Margin % →

What does a Pretax Margin % of % mean?

Xenon Pharmaceuticals (XENE) has a Pretax Margin % of % as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Xenon Pharmaceuticals and its competitors. According to the industry distribution chart, Xenon Pharmaceuticals ranks #999999 out of 946 companies in the Biotechnology industry.

Is Xenon Pharmaceuticals' Pretax Margin % too high?

Xenon Pharmaceuticals' current Pretax Margin % is %. Based on the distribution chart, Xenon Pharmaceuticals ranks #999999 out of 946 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Xenon Pharmaceuticals has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.

How does Xenon Pharmaceuticals' Pretax Margin % compare to CRSP and CGON?

According to the Biotechnology industry distribution chart, Xenon Pharmaceuticals ranks #999999 out of 946 companies for Pretax Margin %. This places Xenon Pharmaceuticals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Pretax Margin % for a Biotechnology company?

A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Pretax Margin % mean?

A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Xenon Pharmaceuticals and its competitors. Xenon Pharmaceuticals's current Pretax Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Xenon Pharmaceuticals stock overvalued right now?

Xenon Pharmaceuticals (XENE) has a current Pretax Margin % of %. The current Pretax Margin % is %. Xenon Pharmaceuticals' overall GF Score™ is 25/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Pretax Margin % calculated?

Pretax Margin % is calculated from a company's financial statements. For Xenon Pharmaceuticals (XENE), the current Pretax Margin % is % as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Xenon Pharmaceuticals Business Description

Industry Healthcare Biotechnology

Comparable Companies CRSP CGON DNTH LEGN TGTX CAI SRRK LGND COGT RYTM VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Other Exchanges XP0:Germany

Address 200-3650 Gilmore Way, Burnaby, BC, CAN, V5G 4W8

Website https://www.xenon-pharma.com

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

25GF Score

Get the complete analysis for XENE

Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$59.74

Price

View XENE Analysis

See Pretax Margin % data for all stocks →